Q4 2022 Quoin Pharmaceuticals Ltd Earnings Call Transcript
Good day and welcome to the Quoin Pharmaceuticals Ltd. fourth-quarter financial results and business update conference call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Gordon Dunn, Chief Financial Officer. Please go ahead.
Thank you and good morning. We appreciate you joining us on today's conference call. With me on the call are Dr. Michael Myers, CEO; and Denise Carter, COO.
We're pleased to provide an update on our progress throughout the fourth quarter of 2022 and for the year as a whole and discussing Quoin Pharmaceuticals' financial results. Please note that our operational and financial results' press release is now available on Quoin's website.
To begin, Michael will provide a corporate, clinical, and operational update, following which, I'll review our Q4 and full-year 2022 financial results. I will then hand the call back to Michael for closing comments. We will also be pleased to answer any questions at the end of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |